financetom
Business
financetom
/
Business
/
Canadian miner Thor Explorations' Q3 revenue hits $69.5 mln on high gold prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian miner Thor Explorations' Q3 revenue hits $69.5 mln on high gold prices
Oct 15, 2025 2:10 AM

Overview

* Thor Explorations Q3 2025 rev at $69.5 mln, driven by high gold prices

* Company maintains FY 2025 production and cost guidance, continues exploration activities

* Gold production at Segilola mine supports strong operational performance

Outlook

* Thor Explorations ( THXPF ) maintains FY 2025 gold production guidance at 85,000 to 95,000 oz

* Company maintains FY 2025 all-in sustaining cost (AISC) guidance at $800 to $1,000 per ounce

* Thor Explorations plans additional drilling at Guitry and Marahui in Q4 2025

Result Drivers

* HIGH GOLD PRICES - Realized price of $3,535 per ounce contributed to strong revenue

* RISING STOCKPILES - Ore stockpile increased by 2,977 oz to 44,069 oz of gold at an average grade of 0.83 g/t

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $69.50

Revenue mln

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
Apr 22, 2024
08:45 AM EDT, 04/22/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Monday that it has selected a move-forward expansion dose for a mid-stage trial evaluating its IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, or NSCLC. Squamous NSCLC has been identified as the most sensitive tumor type of IDE397 monotherapy, the company said. There are more than...
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Apr 22, 2024
(Reuters) -Kroger ( KR ) and Albertsons Cos ( ACI ) said on Monday that they have amended their definitive agreement with C&S Wholesale Grocers for the sale of assets in connection with their proposed merger. The companies have updated their divestiture package to increase the total store count by 166 to include 579 stores that will be sold to...
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Apr 22, 2024
08:47 AM EDT, 04/22/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Monday that it has signed an in-license agreement with Cornell University to expedite the development of investigational gene therapy candidate LX2006 to treat Friedreich ataxia cardiomyopathy. Under the deal, Lexeo said it has acquired certain rights, including rights to current and future data generated in an ongoing...
Red Pine Exploration Says Michael Michaud Joining as its President & CEO and as a Member of its Board; He Has Experience With Wesdome and Iamgold
Red Pine Exploration Says Michael Michaud Joining as its President & CEO and as a Member of its Board; He Has Experience With Wesdome and Iamgold
Apr 22, 2024
08:42 AM EDT, 04/22/2024 (MT Newswires) -- Red Pine Exploration Inc. ( RDEXF ) on Monday announced that Michael Michaud will be joining Red Pine as its President & Chief Executive Officer and as a member of its board of directors. According to a statement, Michaud is a Professional Geologist with over 30 years of experience in domestic and international...
Copyright 2023-2026 - www.financetom.com All Rights Reserved